Observational Study
Copyright ©The Author(s) 2017.
World J Gastroenterol. Feb 28, 2017; 23(8): 1458-1468
Published online Feb 28, 2017. doi: 10.3748/wjg.v23.i8.1458
Figure 1
Figure 1 Selection and enrollment of cirrhotic patients to the study. HCV: Hepatitis C virus; NAFLD: Nonalcoholic fatty liver disease.
Figure 2
Figure 2 Prevalence of metabolic factors and of cardiovascular complications in cryptogenic cirrhosis and hepatitis C virus-related cirrhosis. All factors are significantly higher in cryptogenic cirrhosis (P < 0.01 vs HCV-related cirrhosis). HCV: Hepatitis C virus; IFG: Impaired fasting glucose.
Figure 3
Figure 3 Occurrence of hepatocellular carcinoma among 102 patients with cryptogenic cirrhosis and 110 patients with hepatitis C virus-related cirrhosis and its distribution among Child-Pugh class. HCV: Hepatitis C virus; HCC: Hepatocellular carcinoma.
Figure 4
Figure 4 Cumulative probability of overall survival after cirrhosis detection according to different significant predictors of mortality. A: Cumulative probability of overall survival according to age at diagnosis; P = 0.002 by log-rank test; B: Cumulative probability of overall survival according to Child Class at diagnosis; P < 0.001 by log-rank test; C: Cumulative probability of overall survival according to baseline sodium levels; P = 0.020 by log-rank test; D: Cumulative probability of overall survival according to baseline creatinine levels; P = 0.017 by log-rank test.